Clinical Trial Update: Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Surufatinib in advanced hepatocellular carcinoma based on single-cell sequencing analyses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN